Microbot Medical MBOT Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Returns | |||||
| Return on equity | -32.4%+253pp | -285%-103pp | -182.2%-60.7pp | -121.5%-63.1pp | |
| Return on assets | -30%+129pp | -159.4%-39.2pp | -120.2%-20.1pp | -100.1%-47.6pp | |
| Return on invested capital | -39.3%+794pp | -833%-573pp | -260.3%+126pp | -386.2%-63.6pp | |
| Liquidity | |||||
| Current ratio | 23.3×+21.0× | 2.4×+0.3× | 2.1×-2.2× | 4.3×-3.7× | |
| Quick ratio | 23.2×+20.8× | 2.4×+0.3× | 2.1×-2.2× | 4.3×-3.7× | |
| Cash ratio | 1.1×-0.1× | 1.3×+0.6× | 0.7×-0.5× | 1.2×-5.6× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Interest coverage | -11.5×+52.4× | -63.9×+11.9× | -75.8×— | —— | |
| Per Share | |||||
| Book value per share | $1.69+651% | $0.23-48.9% | $0.44-56.0% | $1.00-50.4% | |
| Valuation | |||||
| Market capitalization | $128.28M+36.1% | $18.96M-1.2% | $19.2M-19.2% | $23.75M-55.4% | |
| Enterprise value | $125.53M+39.0% | $15.96M-5.9% | $16.96M-22.1% | $21.77M-46.2% | |
| Price / book | 1.7×-1.4× | 5.4×+1.1× | 4.3×+1.0× | 3.3×-0.4× | |
| Free cash flow yield | -12%-1.5pp | -46.7%— | —— | -49%-31.3pp | |
| Earnings yield | -11.1%+2.4pp | -60.3%-4.4pp | -55.9%-0.5pp | -55.4%-34.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Microbot Medical's ratios come from?
- Every ratio is computed from Microbot Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
